AngioDynamics hosts virtual Cardiovascular Investor Event on April 2, 2025

ANGIODYNAMICS INC

Event presentation slides furnished as Exhibit 99.1, but no specific financial or operational updates disclosed in filing.
Company focuses on cardiovascular technologies; no material new data or guidance provided.
Forward-looking statements caution about risks including competition, regulatory approvals, and economic conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.